Establishment of a monkey kidney epithelial cell line with the BARF1 open reading frame from Epstein-Barr Virus
We previously reported that the BARF1 (BamH1-A right frame 1) gene product from Epstein-Barr Virus (EBV) may have oncogenic properties since injection into new-born rats of transfected cell lines resulted in the development of BARF1 expressing tumors, which were agressive in the case of murine fibro...
Gespeichert in:
Veröffentlicht in: | Oncogene 1997-06, Vol.14 (25), p.3073-3081 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | We previously reported that the
BARF1
(BamH1-A right frame 1) gene product from Epstein-Barr Virus (EBV) may have oncogenic properties since injection into new-born rats of transfected cell lines resulted in the development of
BARF1
expressing tumors, which were agressive in the case of murine fibroblasts and transient in that of human B lymphocytes. As EBV has been associated with nasopharyngeal carcinoma (NPC) and evidence of
BARF1
transcription in this cancer was emerging from our biopsy analyses, we examined the effects of
BARF1
transfection into primate primary epithelial cells. The expression of the
BARF1
open reading frame in primary monkey kidney epithelial cells led us to the establishment of continuously dividing lines. The
BARF1
transfectants showed the major characteristics of immortalized cells: morphological change, short cell doubling time, ability to divide at low cell density and continuous growth over 50 passages. Injection of BARF1 transfectants into nude mice did not induce any tumor. Established subclones were shown to be epithelial cells expressing known keratins as well as the
BARF1
coded mRNA and protein. This is the first report indicating that expression of the
BARF1
gene product in primary epithelial cells may contribute to the establishment of cell lines. |
---|---|
ISSN: | 0950-9232 1476-5594 |
DOI: | 10.1038/sj.onc.1201128 |